Article (Scientific journals)
Therapeutic peptides for chemotherapy: trends and challenges for advanced delivery systems
Ilangala Booka, Ange; Lechanteur, Anna; Fillet, Marianne et al.
2021In European Journal of Pharmaceutics and Biopharmaceutics
Peer Reviewed verified by ORBi
 

Files


Full Text
Therapeutic peptides for chemotherapy_ trends and challenges for advanced delivery systems _ Enhanced Reader.pdf
Author preprint (23.65 MB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Therapeutic peptides; stability; cancer therapy; drug delivery; active targeting; nanomedicines
Abstract :
[en] The past decades witnessed an increasing interest in peptides as clinical therapeutics. Rightfully considered as a potential alternative for small molecule therapy, these remarkable pharmaceuticals can be structurally fine-tuned to impact properties such as high target affinity, selectivity, low immunogenicity along with satisfactory tissue penetration. Although physicochemical and pharmacokinetic challenges have mitigated, to some extent, the clinical applications of therapeutic peptides, their potential impact on modern healthcare remains encouraging. According to recent reports, there are more than 400 peptides under clinical trials and 60 were already approved for clinical use. As the demand for efficient and safer therapy became high, especially for cancers, peptides have shown some exciting developments not only due to their potent antiproliferative action but also when used as adjuvant therapies, either to decrease side effects with tumor-targeted therapy or to enhance the activity of anticancer drugs via transbarrier delivery. The first part of the present review gives an insight into challenges related to peptide product development. Both molecular and formulation approaches intended to optimize peptide's pharmaceutical properties are covered, and some of their current issues are highlighted. The second part offers a comprehensive overview of the emerging applications of therapeutic peptides in chemotherapy from bioconjugates to nanovectorized therapeutics.
Research center :
CIRM - Centre Interdisciplinaire de Recherche sur le Médicament - ULiège
Disciplines :
Oncology
Author, co-author :
Ilangala Booka, Ange  ;  Université de Liège - ULiège > Département de pharmacie > Développement de nanomédicaments
Lechanteur, Anna  ;  Université de Liège - ULiège > Département de pharmacie > Pharmacognosie
Fillet, Marianne ;  Université de Liège - ULiège > Département de pharmacie > Analyse des médicaments
Piel, Géraldine ;  Université de Liège - ULiège > Département de pharmacie > Développement de nanomédicaments
Language :
English
Title :
Therapeutic peptides for chemotherapy: trends and challenges for advanced delivery systems
Alternative titles :
[en] Belgique
Publication date :
24 July 2021
Journal title :
European Journal of Pharmaceutics and Biopharmaceutics
ISSN :
0939-6411
eISSN :
1873-3441
Publisher :
Elsevier, Amsterdam, Netherlands
Peer reviewed :
Peer Reviewed verified by ORBi
Funders :
F.R.S.-FNRS - Fonds de la Recherche Scientifique [BE]
Available on ORBi :
since 09 September 2021

Statistics


Number of views
102 (30 by ULiège)
Number of downloads
410 (8 by ULiège)

Scopus citations®
 
15
Scopus citations®
without self-citations
15
OpenCitations
 
7

Bibliography


Similar publications



Contact ORBi